Dr. Jacob Jonathan Mayfield, MD

Dr. Mayfield practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Dr. Mayfield's NPI, 1235660689, was assigned on March 27, 2017. Dr. Mayfield graduated from University of New Mexico School of Medicine in 2017. Dr. Mayfield holds New Mexico license MD2023-0440.

Dr. Mayfield's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Dr. Mayfield's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. Dr. Mayfield is also affiliated with Presbyterian Santa Fe Medical Center. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Mayfield to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mayfield practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mayfield's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mayfield is licensed in New Mexico.

CMS data shows 1,774 Medicare services from Dr. Mayfield across 22 procedure codes in 2024, for 1,238 Medicare patients. Medicare paid $59,029 for them.

CMS counts 1,238 Medicare patients who saw Dr. Mayfield in 2024. The largest group is 65 to 74, with 506 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mayfield's median patient age at 63, with 51% women.

In 2024, Dr. Mayfield wrote 1,702 Medicare Part D claims for 372 patients. 85% of them were for generic drugs. CMS names the drug for 1,596 of them, across 26 drugs with 11 or more claims each, at $294,258 in total drug cost. In 2023, CMS named 335 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Mayfield for performance year 2024, reported as part of a group. Dr. Mayfield accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Dr. Mayfield, published from 2016 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Electrocardiography, Acute Coronary Syndrome and Dyspnea. Dr. Mayfield has published most often in Commun Med (Lond). Dr. Mayfield's most frequent co-authors are Geoffrey Huang Tison, MD, MPH, Maria R. Abraham, MD and Neal A. Chatterjee, MD.

CMS Open Payments shows 19 general payments to Dr. Mayfield from 9 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. HeartFlow, Inc. paid the most, $527.

Dr. Mayfield graduated from University of New Mexico School of Medicine in 2017.